慢性肝病患者的远程医疗干预:一项系统综述
该系统综述检索截至2022年1月10日的PubMed/EMBASE,纳入43项研究,评估远程医疗干预在慢性肝病中的结局。丙型肝炎治疗中远程医疗组持续病毒学应答率与对照组或历史队列无统计学显著差异;肝移植相关评估与转诊率改善、短期再入院率降低;非酒精性脂肪性肝病体重减轻结局改善;至少一次远程医疗接触的慢性肝病患者死亡风险降低。
要点
- 丙型肝炎远程医疗组持续病毒学应答率与对照组或历史队列无统计学显著差异。
- 肝移植相关远程医疗干预显示评估与转诊率改善、短期再入院率降低。
- 非酒精性脂肪性肝病远程医疗干预显示体重减轻结局改善。
核心结论
- 慢性肝病患者的远程医疗干预与传统就诊相比持续显示等效或改善的临床结局。
- 远程医疗可弥合慢性肝病患者获得医疗服务的差距,同时维持医疗服务不足人群的照护质量。
研究设计与样本
- 系统综述,检索PubMed/EMBASE自建库至2022年1月10日,由两名作者独立筛选摘要,分歧由第三名审稿人解决。
- 纳入任何类型的慢性肝病包括移植后患者,共筛查4250项研究,43项符合纳入标准。
- 因数据异质性未进行Meta分析;观察性研究采用纽卡斯尔-渥太华量表进行质量评估,临床试验采用Cochrane偏倚风险工具。
主要发现
- 43项纳入研究中28项报告丙型肝炎治疗结局,所有研究显示远程医疗组与对照组或历史队列的持续病毒学应答率无统计学显著差异。
- 8项评估肝移植相关流程与结局的研究显示移植评估与转诊率改善、短期再入院率降低。
- 3项随机对照试验和1项观察性研究显示非酒精性脂肪性肝病体重减轻结局改善。
- 1项回顾性研究显示至少1次远程医疗接触的慢性肝病患者死亡风险降低。
临床怎么用
- 原文结论指出远程医疗干预在慢性肝病患者中持续显示等效或改善的临床结局,可弥合获得医疗服务的差距并维持医疗服务不足人群的照护质量。
局限性
- 因数据异质性未进行Meta分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIM: Telehealth interventions may improve access to care, disease-specific, and quality outcomes in chronic liver diseases (CLDs). We aimed to systematically evaluate outcomes of telehealth interventions in CLDs. MATERIALS AND METHODS: We used key terms and searched PubMed/EMBASE from inception to January 10, 2022. Two authors independently screened abstracts. Disagreements were resolved by a third reviewer. We included any type of CLD, including posttransplant patients, and extracted outcomes as defined by authors for each etiology of CLD (sustained virological response in HCV or weight loss in NAFLD). Meta-analysis was not performed because of the heterogeneity of data. Quality assessment was performed using the Newcastle-Ottawa Scale for observational studies and the Cochrane Risk of Bias tool for clinical trials. RESULTS: Of 4250 studies screened, 43 met the inclusion criteria. Of these, 28 reported HCV treatment outcomes. All studies showed no statistically significant differences between sustained virological response rates in TH groups compared with control groups or historic cohorts. Eight studies evaluating liver transplant-related processes and outcomes demonstrated improved rates of transplant evaluation and referrals and decreased short-term readmission rates. Three randomized controlled trials and 1 observational study on NAFLD showed improved weight loss outcomes. One retrospective study showed reduced mortality risk in CLD patients with at least 1 TH encounter. CONCLUSIONS: TH interventions in patients with CLDs consistently show equivalent or improved clinical outcomes compared with traditional encounters. TH in CLDs can bridge the gap in access while maintaining the quality of care for underserved populations.
引用
- Muftah AA, Banala C, Raasikh T, et al. Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology. 2023. PMID: 36632994. doi:10.1097/HEP.0000000000000265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。